Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
06/1999
06/15/1999US5912114 Wound diagnosis by quantitating cortisol in wound fluids
06/15/1999US5911997 Relaxin-like factor and methods and uses thereof
06/15/1999US5911989 Antibodies
06/15/1999US5911970 Antitumor agents and anticarcinogenic agents
06/15/1999US5911952 For detecting small amounts of substances within living cells where fluorescence intensity attenuates over time after excitation; light is divided into two wavelength zones so that variations, with time, between zones can be measured
06/15/1999US5911872 Electroconductive elements coupled to and separated from resistaors
06/15/1999CA2249778A1 Competitive apo-peroxidase assay
06/15/1999CA2153878C Biosensing meter with ambient temperature estimation method and system
06/15/1999CA2153877C Biosensing meter with fail/safe procedures to prevent erroneous indications
06/15/1999CA2054689C An immunoassay method for determining the specificity of binding of a monoclonal antibody to an antigen
06/15/1999CA2014826C Method for screening substances having iga induction potential and bacterial strains of genus bifidobacterium
06/15/1999CA1340595C Method for early detection of lung cancer
06/15/1999CA1340594C Detection of chemicals by immunoassay
06/11/1999CA2254308A1 Process and device for measuring physical characteristics of a porous sample by means of fluid displacement via centrifuging
06/10/1999WO1999028856A1 Method of cancer cell detection
06/10/1999WO1999028753A1 Application of tryptophan hydroxylase, a novel autoantigen, in immunoassays, drug production and treatment
06/10/1999WO1999028752A1 Diagnosis of autoimmune adrenal disease
06/10/1999WO1999028751A1 Immunoassay method and kit
06/10/1999WO1999028749A1 USES OF p27 IN PROSTATE CANCER
06/10/1999WO1999028748A2 Hla-e binding
06/10/1999WO1999028747A1 Methods for screening therapeutically effective agents
06/10/1999WO1999028746A1 A bacterial multi-hybrid system and applications
06/10/1999WO1999028745A1 Identification and characterization of interacting molecules by automated interaction mating
06/10/1999WO1999028744A1 Identification and characterization of interacting molecules
06/10/1999WO1999028743A1 Device for investigating respiratory tract diseases and diagnostic agents
06/10/1999WO1999028742A1 Method and device for disintegrating biological cells for the purpose of extracting and analyzing cell contents
06/10/1999WO1999028741A1 Method for measuring iodine, reaction instrument for specimen pretreatment, and device for hermetically sealing reaction instrument for specimen pretreatment
06/10/1999WO1999028737A1 Method and apparatus for continuously monitoring an aqueous flow to detect and quantify ions
06/10/1999WO1999028736A1 Instrument
06/10/1999WO1999028731A1 Method and device for studying the effect of a supercritical fluid on the transition of a material from one condensed phase to the other and their application in the case of a polymer material
06/10/1999WO1999028726A1 A sampling device for thermal analysis
06/10/1999WO1999028603A2 Measurement of contaminant components in exhaust gas and reduction of excessive contaminant emissions during cold starts and while driving
06/10/1999WO1999028507A1 Methods for the detection of chromosomal aberrations
06/10/1999WO1999028506A2 Cancer susceptibility mutations of brca2
06/10/1999WO1999028504A1 Surface treatments for dna processing devices
06/10/1999WO1999028501A1 Fluorometric method for monitoring and detecting nucleic acid amplification
06/10/1999WO1999028500A1 Fluorimetric detection system of a nucleic acid
06/10/1999WO1999028499A1 Method for measuring the apoptosis
06/10/1999WO1999028495A1 Method for analyzing intracellular components
06/10/1999WO1999028493A2 Method for identifying inhibitors of g-protein coupled receptor hibef51
06/10/1999WO1999028486A1 Methods of isolating and using cd7+cd34-lin-hematopoietic cells
06/10/1999WO1999028484A1 Proteinase inhibitor fusion proteins
06/10/1999WO1999028478A1 Preparation and use of recombinant influenza a virus m2 constructs and vaccines
06/10/1999WO1999028475A2 Chlamydia trachomatis genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection
06/10/1999WO1999028471A2 ANTIBODIES, INCLUDING Fv MOLECULES, AND IMMUNOCONJUGATES HAVING HIGH BINDING AFFINITY FOR MESOTHELIN AND METHODS FOR THEIR USE
06/10/1999WO1999028467A1 Human thyroid protein zsig45 and dna encoding same
06/10/1999WO1999028461A2 Methods and means for inducing apoptosis by interfering with bip-like proteins
06/10/1999WO1999028456A1 Splice variants for human 5-ht4 serotonin receptor and their applications, in particular for screening
06/10/1999WO1999028453A2 Transgenic non-human mammals with an oncogenic mutant of raf gene 1
06/10/1999WO1999028439A2 Erythrovirus and its applications
06/10/1999WO1999028437A1 Simulated biological dissolution and absorption system
06/10/1999WO1999028347A1 Method of designing agonists and antagonists to igf receptor
06/10/1999WO1999028344A2 Synthetic peptides containing citrulline recognized by rheumatoid arthritis sera as tools for diagnosis and treatment
06/10/1999WO1999028342A2 Low-voltage activated calcium channel compositions and methods
06/10/1999WO1999028334A1 Novel genes encoding proteins involved in mitotic checkpoint control and methods of use thereof
06/10/1999WO1999028149A1 High-sensitivity capacitive oil deterioration and level sensor
06/10/1999WO1999028047A2 Artificial surface with predetermined affinity
06/10/1999WO1999028038A1 Device and apparatus for conducting an assay
06/10/1999WO1999028037A1 Device for measuring physiological parameters
06/10/1999WO1999027944A1 Prevention and treatment of amyloidogenic disease
06/10/1999WO1999027897A1 Site-specific preparation of polyethylene glycol-grf conjugates
06/10/1999WO1999027854A1 Analytic measuring device with a puncturing aid
06/10/1999WO1999027848A1 Multiplex sensor and method of use
06/10/1999WO1999015540A3 Method for producing a pentopyranosyl nucleoside
06/10/1999WO1999014331A3 Cyclin-dependent kinase inhibitors and uses thereof
06/10/1999WO1999014241A3 Compositions and methods for the treatment of immune related diseases
06/10/1999WO1999013095A3 Use of multivalent chimeric peptide-loaded, mhc/ig molecules to detect, activate or suppress antigen-specific t cell-dependent immune responses
06/10/1999WO1999012033A3 Method and kit for identifying interactions between proteins or peptides
06/10/1999WO1999007737A3 Lsr receptor, cloning and uses
06/10/1999WO1999006545A8 Composition and method for the detection of diseases associated with amyloid-like fibril or protein aggregate formation
06/10/1999WO1999005175A3 Diagnosis and treatment of diseases using anti-anti-t-cell receptor vbeta anti-bodies or peptides which are recognized by said antibodies, and endocrine secretion regulatory protein i (esrp1)
06/10/1999WO1999000671A3 Method for identification of tumor antigens with autoantibodies in serum
06/10/1999WO1998050065A3 The use of biologically active substances for influencing the extracellular area of sensory cells and method for controlling the administration of active substances and device used therein
06/10/1999DE19845195A1 Determining properties of reactive resins
06/10/1999DE19753851A1 Vorrichtung zum kapillaren Flüssigkeitstransport An apparatus for capillary liquid transport
06/10/1999DE19753850A1 Probennahmevorrichtung Sampling device
06/10/1999DE19753849A1 Analytisches Testelement mit sich verjüngendem Kapillarkanal Analytical test element with tapered capillary
06/10/1999DE19753847A1 Analytisches Testelement mit Kapillarkanal Analytical test element with capillary
06/10/1999DE19751971A1 Measurement of dissolved content of carbon dioxide in drink
06/10/1999DE19751363A1 Detecting substance emission of an object
06/10/1999DE19749029A1 Spray water protection and calibration unit for stationary gas warning appliance
06/10/1999CA2350036A1 Measurement of contaminant components in exhaust gas and reduction of excessive contaminant emissions during cold starts and while driving
06/10/1999CA2325006A1 Device and apparatus for conducting an assay
06/10/1999CA2313014A1 Methods for the detection of chromosomal aberrations
06/10/1999CA2312920A1 Prevention and treatment of amyloidogenic disease
06/10/1999CA2312833A1 Simulated biological dissolution and absorption system
06/10/1999CA2312421A1 Surface treatments for dna processing devices
06/10/1999CA2312379A1 A bacterial multi-hybrid system and applications
06/10/1999CA2312195A1 Low-voltage activated calcium channel compositions and methods
06/10/1999CA2312050A1 Proteinase inhibitor fusion proteins
06/10/1999CA2312048A1 Human thyroid protein zsig45 and dna encoding same
06/10/1999CA2312007A1 Methods and means for inducing apoptosis by interfering with bip-like proteins
06/10/1999CA2311954A1 Process for measuring apoptosis
06/10/1999CA2311927A1 Identification and characterization of interacting molecules
06/10/1999CA2311926A1 Method of designing agonists and antagonists to igf receptor
06/10/1999CA2311705A1 Identification and characterization of interacting molecules by automated interaction mating
06/10/1999CA2311680A1 Cancer susceptibility mutations of brca2
06/10/1999CA2311429A1 Method and device for disintegrating biological cells for the purpose of extracting and analyzing cell contents
06/10/1999CA2310541A1 Splice variants for human 5-ht4 serotonin receptor and their applications, in particular for screening
06/10/1999CA2310468A1 Multiplex sensor and method of use